Contact Us
Enabling a new future built on our greatest untapped resource.
Fat is the future.TM
Enabling a new future built on our greatest untapped resource.
Fat is the future.TM

As the largest source of regenerative cells in the body, Fat (adipose tissue) which is typically discarded, presents a universal opportunity for an ever-expanding multitude of applications in:

Aesthetics
Standard processing in aesthetic procedures
Face Contouring
Face Contouring Fat, a healthier alternative to artificial fillers, is projected to tap into a market valued at $9B by 2028.
Breast Contouring
Breast Contouring Fat, as a natural alternative to breast implants, is poised to disrupt a market expected to hit $4B by 2028.
Butt Lift
Butt Lift The hottest trend, powered by social media - revenue is forecasted to reach $6.6B by 2028.
Skin Health
Wrinkle Reduction

Wrinkle Reduction

As a natural alternative to synthetic injectables, fat grafting for wrinkle reduction is expected to capture an increasing share of the market and contribute to the projected $21B anti-wrinkle market by 2030.

Blemishes

Blemishes

As consumers continue to prioritize natural skincare, the demand for blemish treatments using organic ingredients, such as fat, is poised to capture a significant share of a market that is expected to grow to $17.40 B by 2028.

Scar Reduction

Scar Reduction

Fat grafting is rapidly emerging as a leading option for scar reduction, offering a natural and effective solution, which improves skin texture and fills in scars and is contributing to the scar treatment market's projected growth to over $52.8 B by 2030​.

REGENERATIVE THERAPY

Emerging as powerful tool in regenerative medicine
Hair Restoration (Allopecia)

Hair Restoration

Regenerating hair follicles, providing a novel solution for Alopecia.

Myocardium Restoration (e.g. Heart Attack)

Myocardium Restoration

Repairing heart tissue post-heart attack.

Nervous System Rebuilding (e.g. SCI and TBI)

Nervous System Rebuilding

Restoring neural pathways, heralding breakthroughs in SCI and TBI treatment.

Skin Rejuvenation (e.g. Skin Aging)

Skin Rejuvenation

Revitalizing aging skin, offering a natural route to youthfulness.

Wound Healing (e.g. DFUs)

Wound Healing

Accelerating the healing of wounds, including diabetic foot ulcers.

Cartilage Repair (e.g. Osteoarthritis)

Cartilage Repair

Repairing damaged cartilage, creating new hope for osteoarthritis patients.

Problem

Today, fat remains grossly underutilized.

Presently, four primary pain points prevent the efficient and effective use of fat in medical applications.

  • Limited Volumes

  • Labor Intensive

  • Slow Processing

  • Unpredictable Grafts

Solution

Sayenza Bio integrates solutions to these four challenges into a unified platform. Our platform is the key to a new era in fat utilization.

Sayenza is the key to unlocking a new universe of personalized medical applications harnessing the power of fat.
Extraction & Collection
Efficient and minimally invasive fat extraction
Processing & Refinement

Automated processing w/ Regenerative Cell enrichment

Delivery & Application
Ready-to-use therapeutic fat graft
Sayenza Bio is building a complete ecosystem of solutions that advances the handling of fat at every touchpoint.
Processing & Refinement Solution

Automated processing w/ Regenerative Cell enrichment.

Fully Automated

Reusable Platform

Self-Contained

High Precision

Team
derek
Derek Banyard
MD, MS, MBA
Founder
CEO
Read More
mark
Mark
Ross
Chief Operating
Officer
Read More
Floyd_Amuchie
Floyd
Amuchie
Chief Financial
Officer
Read More
Co-Founders / Directors
jered
Jered Haun
PhD
Co-founder, Advisor

Read More
alan
Alan Widgerow
MBBCh, MMed
Co-founder, Advisor

Read More
Validation of Vision – Key Advisors

Backed by:

Recognition & Partners Supporting our work:

Get In Touch With Us Today

For  any inquiries or information regarding our innovative regenerative medicine technologies, please contact us through our email info@sayenza.com.

Facebook-f Twitter Linkedin Instagram

Blog & News

Derek Banyard
MD, MS, MBA

Founder, CEO

Linkedin Twitter

Dr. Banyard is a surgeon and internationally acclaimed adipose stem cell researcher. He left plastic surgery residency to found Sayenza Biosciences and has been recognized with several grants and awards. He is former chief scientist at the Center for Tissue Engineering at UC Irvine where his early research earned him a coveted Regenerative Medicine Training grant from the California Institute for Regenerative Medicine as well as the National Endowment for Plastic Surgery grant from the Plastic Surgery Foundation. He has co-authored over 100 abstracts, posters, and publications.

Mark Ross
Chief Operating Officer
Linkedin
Over 20 years experience managing operations, supply chain, quality assurance, and practice managment. Worked at Abbott, Medtronic and Microsoft. Previous experience gaining PMA approval with zero findings for medical device at Endologix. MBA, Santa Clara University, BA, Hope International, LEAN Six Sigma Green Belt.
Floyd Amuchie
Chief Financial Officer
Linkedin

Floyd brings Over 20 years of experience leading finance, systems, and operating teams for complex manufacturing, technology, and services organizations in the public and private space. He has raised over $1 Billion in growth capital through complex equity and debt transactions, including confidentially marketed public offerings, at-the-market offerings, and convertible debt. Floyd was part of the executive team that completed the successful acquisition and integration of two businesses, as well as the divestiture of two business units for significantly more than recent valuation. He built out best in class finance organizations at three public companies and was the 2021 Orange County Business Journal CFO of the Year.

Jered Haun
PhD
Co-founder, Engineering Consultant
Linkedin

Dr. Haun is an Associate Professor of Biomedical Engineering and a member of the Chao Family Comprehensive Cancer Center and Center for Advanced Design and Manufacturing of Integrated Microfluidics at UC Irvine. Professor Haun is an expert in tissue processing and microfluidics and a previous Chan Zuckerberg Grant recipient.

Alan Widgerow
MBBCh, MMed

Co-founder, Clinical Consultant

Linkedin

Dr. Widgerow is professor of plastic surgery and director of the Center for Tissue Engineering in the Department of Plastic Surgery at UC Irvine. He has over 20 years of experience as a private practice plastic surgeon and has authored over 15 patents and 200 abstracts, posters, and publications. He has been involved in several businesses and startups, and currently serves as chief medical officer at Alastin Skincare, the fastest growing professional skincare brand in the U.S., which was recently acquired by Galderma making Dr. Widgerown Chief Scientific Officer and Head of Skin Science Center of Innovation at Galderma.

Contact Us